Medifast Q4 revenue falls 37% to $75.1M; net loss $18.1M, guides FY26 rev $270-300M

MEDIFAST INC

2025-FY EPS reported -$1.70 revenue$385,788,000

Revenue $75.1M, down 36.9% YoY; active earning coaches down 40.6% to 16,100.
Net loss $18.1M ($1.65 EPS) includes $12.1M non-cash tax valuation allowance ($1.10/sh).
Full year 2025 revenue $385.8M (-36% YoY); net loss $18.7M (-$1.70 EPS).
Guides Q1 2026 rev $65-80M, loss $0.15-$0.70/sh; FY26 rev $270-300M, loss $1.55-$2.75/sh.

item 2.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001628280-26-008641
form_type: 8-K
ticker: MED
cik: 0000910329
company_name: MEDIFAST INC
filed_at: 2026-02-17T23:59:59+00:00
discovered_at: 2026-05-14T18:02:38.009142+00:00
generated_at: 2026-05-16T02:40:13.234023+00:00
sec_items: ["2.02", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001628280-26-008641
json_url: https://secwatch.observer/filing/0001628280-26-008641.json
markdown_url: https://secwatch.observer/filing/0001628280-26-008641.md
text_url: https://secwatch.observer/filing/0001628280-26-008641.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/910329/000162828026008641/0001628280-26-008641-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/910329/000162828026008641/med-20260217.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001628280-26-008641

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.